This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International: COVID-19 Therapeutic Development & Production
April 27-28, 2021
Delivered in a 100% Virtual FormatBritish Summer Time (BST)

Satish Ravetkar, Ph.D.
Executive Director at Serum Institute of India Pvt Ltd.


Dr. S.D. Ravetkar is an Executive Director and member of Board with Serum Institute of India Ltd. Apart from his Doctorate he holds degrees in Management and Finance. He has authored various research articles in national and international journals. He is also on advisory board of various national and international organizations and journals.  He has more than 44 years techno-commercial experience in biotech industry in various areas like QC, production, projects planning & research. At present his major responsibility is manufacturing of Bacterial combination vaccines mainly Pentavalent and Hexavalent vaccine. He has extensively worked on microbial and bioengineering aspects of vaccinology and also expertised on technology transfer. He is listed amongst 15 influential figures in the Asian Vaccine Industry. He is also listed amongst 10 most Influential Leaders in the vaccine Industry 2015.


Agenda Sessions

  • Covid- 19 Vaccine and Challenges